{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:06:19Z","timestamp":1773097579733,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-024-10417-7","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T14:02:26Z","timestamp":1720620146000},"page":"1039-1047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Acetazolamide therapy in patients with acute heart failure: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5320-3040","authenticated-orcid":false,"given":"Tanize Louize","family":"Milbradt","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8117-2784","authenticated-orcid":false,"given":"Renan Yuji Ura","family":"Sudo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7329-5060","authenticated-orcid":false,"given":"Mar\u00edlia Oberto da Silva","family":"Gobbo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0532-8500","authenticated-orcid":false,"given":"Stephen","family":"Akinfenwa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6158-7368","authenticated-orcid":false,"given":"Brenda","family":"Moura","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"issue":"6","key":"10417_CR1","doi-asserted-by":"publisher","first-page":"e027852","DOI":"10.1161\/JAHA.122.027852","volume":"12","author":"T Yan","year":"2023","unstructured":"Yan T, Zhu S, Yin X et al (2023) Burden, trends, and inequalities of heart failure globally, 1990 to 2019: a secondary analysis based on the global burden of disease 2019 study. J Am Heart Assoc 12(6):e027852. https:\/\/doi.org\/10.1161\/JAHA.122.027852","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10417_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ejhf.289","volume":"17","author":"A Mebazaa","year":"2015","unstructured":"Mebazaa A, Yilmaz MB, Levy P et al (2015) Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine, and the Society of Academic Emergency Medicine. Eur J Heart Fail 17(6):544\u2013558. https:\/\/doi.org\/10.1002\/ejhf.289","journal-title":"Eur J Heart Fail"},{"issue":"25","key":"10417_CR3","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1161\/CIRCULATIONAHA.111.019216","volume":"124","author":"JC Kelder","year":"2011","unstructured":"Kelder JC, Cramer MJ, van Wijngaarden J et al (2011) The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation 124(25):2865\u20132873. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.019216","journal-title":"Circulation"},{"issue":"2","key":"10417_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens W, Damman K, Harjola VP et al (2019) The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21(2):137\u2013155. https:\/\/doi.org\/10.1002\/ejhf.1369","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10417_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797\u2013805. https:\/\/doi.org\/10.1056\/NEJMoa1005419","journal-title":"N Engl J Med"},{"issue":"11","key":"10417_CR6","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/ejhf.1492","volume":"21","author":"O Chioncel","year":"2019","unstructured":"Chioncel O, Mebazaa A, Maggioni A et al (2019) Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur J Heart Fail 21(11):1338\u20131352. https:\/\/doi.org\/10.1002\/ejhf.1492","journal-title":"Eur J Heart Fail"},{"issue":"31","key":"10417_CR7","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/eurheartj\/ehad341","volume":"44","author":"SE Yeoh","year":"2023","unstructured":"Yeoh SE, Osmanska J, Petrie MC et al (2023) Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics. Eur Heart J 44(31):2966\u20132977. https:\/\/doi.org\/10.1093\/eurheartj\/ehad341","journal-title":"Eur Heart J"},{"key":"10417_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","volume":"6","author":"M Arrigo","year":"2020","unstructured":"Arrigo M, Jessup M, Mullens W et al (2020) Acute heart failure. Nat Rev Dis Primers 6:16. https:\/\/doi.org\/10.1038\/s41572-020-0151-7","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10417_CR9","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ejhf.1478","volume":"21","author":"FH Verbrugge","year":"2019","unstructured":"Verbrugge FH, Martens P, Ameloot K et al (2019) Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Eur J Heart Fail 21(11):1415\u20131422. https:\/\/doi.org\/10.1002\/ejhf.1478","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10417_CR10","doi-asserted-by":"publisher","first-page":"16526","DOI":"10.20452\/pamw.16526","volume":"133","author":"A Kosiorek","year":"2023","unstructured":"Kosiorek A, Urban S et al (2023) Diuretic, natriuretic, and chloride-regaining effects of oral acetazolamide as an add-on therapy for acute heart failure with volume overload: a single-center, prospective, randomized study. Pol Arch Intern Med 133(12):16526. https:\/\/doi.org\/10.20452\/pamw.16526","journal-title":"Pol Arch Intern Med"},{"issue":"12","key":"10417_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s40261-017-0577-1","volume":"37","author":"T Imiela","year":"2017","unstructured":"Imiela T, Budaj A (2017) Acetazolamide as add-on diuretic therapy in exacerbations of chronic heart failure: a pilot study. Clin Drug Investig 37(12):1175\u20131181. https:\/\/doi.org\/10.1007\/s40261-017-0577-1","journal-title":"Clin Drug Investig"},{"issue":"13","key":"10417_CR12","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens W, Dauw J, Martens P et al (2022) Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 387(13):1185\u20131195. https:\/\/doi.org\/10.1056\/NEJMoa2203094","journal-title":"N Engl J Med"},{"issue":"11","key":"10417_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079327","volume":"8","author":"K Zahedi","year":"2013","unstructured":"Zahedi K, Barone S, Xu J, Soleimani M (2013) Potentiation of the effect of thiazide derivatives by carbonic anhydrase inhibitors: molecular mechanisms and potential clinical implications. PLoS ONE 8(11):e79327. https:\/\/doi.org\/10.1371\/journal.pone.0079327","journal-title":"PLoS ONE"},{"issue":"4","key":"10417_CR14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37792","volume":"15","author":"BA Malik","year":"2023","unstructured":"Malik BA, Nnodebe I et al (2023) Effect of acetazolamide as add-on diuretic therapy in patients with heart failure: a meta-analysis. Cureus 15(4):e37792. https:\/\/doi.org\/10.7759\/cureus.37792","journal-title":"Cureus"},{"key":"10417_CR15","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al (2022) Cochrane handbook for systematic reviews of interventions. \nhttps:\/\/training.cochrane.org\/handbook. (Accessed 24 Nov 2023)."},{"key":"10417_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"10417_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomized trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"10417_CR18","unstructured":"GRADEpro GDT Cochrane GRADEing. Accessed 15 December 2023. https:\/\/methods.cochrane.org\/gradeing\/gradepro-gdt"},{"key":"10417_CR19","unstructured":"R Core Team. (2022). R: A language and environment for statistical computing. https:\/\/www.R-project.org\/"},{"key":"10417_CR20","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.1 (updated September 2020)","author":"MJ Page","year":"2020","unstructured":"Page MJ, Higgins JPT, Sterne JAC (2020) Chapter 13: Assessing the risk of bias due to missing results in a synthesis. In: Higgin JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) Cochrane handbook for systematic reviews of interventions version 6.1 (updated September 2020). Cochrane"},{"issue":"3","key":"10417_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/ac.70.3.3080630","volume":"70","author":"FH Verbrugge","year":"2015","unstructured":"Verbrugge FH, Dupont M, Bertrand PB et al (2015) Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload. Acta Cardiol 70(3):265\u2013273. https:\/\/doi.org\/10.1080\/ac.70.3.3080630","journal-title":"Acta Cardiol"},{"issue":"2","key":"10417_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/ehjacc\/zuaa006","volume":"10","author":"G Tersalvi","year":"2021","unstructured":"Tersalvi G, Dauw J et al (2021) The value of urinary sodium assessment in acute heart failure. Eur Heart J Acute Cardiovasc Care 10(2):216\u2013223. https:\/\/doi.org\/10.1093\/ehjacc\/zuaa006","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"3","key":"10417_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00005344-199703000-00010","volume":"29","author":"H Knauf","year":"1997","unstructured":"Knauf H, Mutschler E (1997) Sequential nephron blockade breaks resistance to diuretics in edematous states. J Cardiovasc Pharmacol 29(3):367\u2013372. https:\/\/doi.org\/10.1097\/00005344-199703000-00010","journal-title":"J Cardiovasc Pharmacol"},{"issue":"12","key":"10417_CR24","doi-asserted-by":"publisher","first-page":"16629","DOI":"10.20452\/pamw.16629","volume":"133","author":"H Kataoka","year":"2023","unstructured":"Kataoka H (2023) Acetazolamide as a potent chloride-regaining diuretic: time to re-evaluate its diverse actions. Pol Arch Intern Med 133(12):16629. https:\/\/doi.org\/10.20452\/pamw.16629","journal-title":"Pol Arch Intern Med"},{"key":"10417_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"KF Adams Jr","year":"2005","unstructured":"Adams KF Jr, Fonarow GC, Emerman CL et al (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209\u2013216. https:\/\/doi.org\/10.1016\/j.ahj.2004.08.005","journal-title":"Am Heart J"},{"issue":"1","key":"10417_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/jrsm.1230","volume":"8","author":"M Borenstein","year":"2017","unstructured":"Borenstein M, Higgins JP, Hedges LV et al (2017) Basics of meta-analysis: I2 is not an absolute measure of heterogeneity. Res Synth Methods 8(1):5\u201318. https:\/\/doi.org\/10.1002\/jrsm.1230","journal-title":"Res Synth Methods"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10417-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-024-10417-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10417-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T08:23:07Z","timestamp":1723018987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-024-10417-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["10417"],"URL":"https:\/\/doi.org\/10.1007\/s10741-024-10417-7","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"3 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. Tanize Louize Milbradt, Renan Yuji Ura Sudo, Mar\u00edlia Oberto da Silva Gobbo, and Dr. Stephen Akinfenwa do not have any conflicts of interest or financial ties to disclosure. Dr. Brenda Moura is a close acquaintance of one of the ADVOR trial\u2019s main investigators. However, the data utilized in our meta-analysis were exclusively sourced from the ADVOR trial\u2019s publicly available publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}